<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shen D</submitter><funding>STI 2030-Major Projects</funding><pagination>1167</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12752173</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Methamphetamine (METH)-induced psychosis (MAP), characterized by transient schizophreniform symptoms, affects approximately 43% of individuals with methamphetamine use disorders (MUD). However, the cortical atrophy pattern associated with MAP remain unclear.&lt;h4>Methods&lt;/h4>Ninety-four male patients with MUD (62 without psychotic symptoms [MA] and 32 MAP) and 61 healthy controls (HCs) underwent high-resolution T1-weighted MRI and clinical assessments. Surface-based morphological (SBM) analysis using FreeSurfer 7.1.1 was conducted to explore cortical thickness and volume difference among groups. We also examined the correlation between brain structural changes and clinical variables.&lt;h4>Results&lt;/h4>The MAP group showed significant cortical thinning in the left superior tem</pubmed_abstract><journal>BMC psychiatry</journal><pubmed_title>Cortical morphological alterations in methamphetamine-induced psychosis: a surface-based morphometry study.</pubmed_title><pmcid>PMC12752173</pmcid><funding_grant_id>2021ZD0202105</funding_grant_id><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Tao H</pubmed_authors><pubmed_authors>Shen D</pubmed_authors><pubmed_authors>Lai M</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Luo D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cortical morphological alterations in methamphetamine-induced psychosis: a surface-based morphometry study.</name><description>&lt;h4>Background&lt;/h4>Methamphetamine (METH)-induced psychosis (MAP), characterized by transient schizophreniform symptoms, affects approximately 43% of individuals with methamphetamine use disorders (MUD). However, the cortical atrophy pattern associated with MAP remain unclear.&lt;h4>Methods&lt;/h4>Ninety-four male patients with MUD (62 without psychotic symptoms [MA] and 32 MAP) and 61 healthy controls (HCs) underwent high-resolution T1-weighted MRI and clinical assessments. Surface-based morphological (SBM) analysis using FreeSurfer 7.1.1 was conducted to explore cortical thickness and volume difference among groups. We also examined the correlation between brain structural changes and clinical variables.&lt;h4>Results&lt;/h4>The MAP group showed significant cortical thinning in the left superior tem</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-06T08:35:16.317Z</modification><creation>2026-05-27T03:12:35.866Z</creation></dates><accession>S-EPMC12752173</accession><cross_references><pubmed>41257616</pubmed><doi>10.1186/s12888-025-07603-8</doi></cross_references></HashMap>